AG Josh Hawley Expands Opioid Marketing Investigation to Seven Additional Pharmaceutical Companies
released on August 30, 2017
found in newsletter: August 2017
Jefferson City, Mo. — Missouri Attorney General Josh Hawley continues to widen his investigation of opioid manufacturers, today announcing the issuance of civil investigative demands to seven major opioid manufacturers. These investigative demands require the manufacturers to provide documents and information relevant to the Attorney General Office’s ongoing investigation of the pharmaceutical industry’s marketing practices for opioids.
The office issued investigative demands to Allergan, Depomed, Insys, Mallinckrodt, Mylan, Pfizer, and Teva Pharmaceuticals.
“Our office is dedicated to stemming the tide of opioid abuse in Missouri,” Hawley said. “We hope that our continuing investigation will aid the fight to build a healthier Missouri and end this epidemic in our state.”
Today’s investigative demands seek documents and information related to the companies’ opioid marketing practices and their involvement with industry organizations that promoted opioids.
In June, Hawley filed a lawsuit against three large drug manufacturing companies—Purdue Pharma, Endo, and Janssen Pharmaceuticals—in the Circuit Court of St. Louis City. That lawsuit alleges, among other things, that the defendants fraudulently misrepresented serious risks posed by the opioids that they manufacture and sell.
“Our state faces an urgent public-health crisis brought on by fraud. Our investigation into those companies that manufacture and market opioids is ongoing,” Hawley said. “We must put an end to this crisis as we fight for the thousands of lives endangered by the opioid epidemic.”
You can read more about the initial lawsuit here.
Original Press Release